Genetically modified human natural killer cell lines

Details for Australian Patent Application No. 2005277831 (hide)

International Classifications

Event Publications

11 January 2007 PCT application entered the National Phase

PCT publication WO2006/023148 Priority application(s): WO2006/023148

12 March 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 10 Feb 2009

9 July 2009 Section 223 Application Received

Fox Chase Cancer Center An application to extend the time from 01 Mar 2006 to 01 Mar 2009 in which to comply with Section 6(c) has been filed . Address for service in Australia - Mallesons Stephen Jaques Level 50 Bourke Place 600 Bourke Street Melbourne VIC 3000 2006

27 August 2009 Section 223 Application Allowed

Fox Chase Cancer Center The time in which to comply with Section 6(c) has been extended to 01 Mar 2009. Address for service in Australia - Mallesons Stephen Jaques Level 50 Bourke Place 600 Bourke Street Melbourne VIC 3000 2006 Extensions of Time, Section 223

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.